Results of General Meeting

AI SummaryClose X

Allergy Therapeutics plc announced that all resolutions were passed at its General Meeting, including the authorization for directors to allot shares up to a nominal amount of £610,000 and to disapply pre-emption rights. These approvals are to facilitate a potential equity raise, which could involve issuing up to 610,000,000 new ordinary shares, approximately 10% of the current issued share capital. The company also posted its Annual Report and Accounts for the year ended 30 June 2025 to shareholders.

Disclaimer*

UK 100

Latest directors dealings